BIONDVAX PHARMACEUTICALS LTD's ticker is BVXVW and the CUSIP is 09073Q113. A total of 2 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $14,000 | -6.7% | 12,000 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $15,000 | +7.1% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $14,000 | -17.6% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $17,000 | -10.5% | 12,000 | 0.0% | 0.00% | -20.0% |
| Q3 2017 | $19,000 | -38.7% | 12,000 | 0.0% | 0.01% | -44.4% |
| Q2 2017 | $31,000 | +82.4% | 12,000 | 0.0% | 0.01% | +50.0% |
| Q1 2017 | $17,000 | +325.0% | 12,000 | 0.0% | 0.01% | +200.0% |
| Q4 2016 | $4,000 | -33.3% | 12,000 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $6,000 | +20.0% | 12,000 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $5,000 | -28.6% | 12,000 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $7,000 | -22.2% | 12,000 | 0.0% | 0.00% | -40.0% |
| Q4 2015 | $9,000 | -10.0% | 12,000 | 0.0% | 0.01% | -16.7% |
| Q3 2015 | $10,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Investment Advisors, LLC | 12,000 | $4,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 72,800 | $27,000 | 0.00% |
| UBS Group AG | 2,001 | $1,000 | 0.00% |